219 related articles for article (PubMed ID: 16704350)
1. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis.
Brunham LR; Singaraja RR; Hayden MR
Annu Rev Nutr; 2006; 26():105-29. PubMed ID: 16704350
[TBL] [Abstract][Full Text] [Related]
2. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
[TBL] [Abstract][Full Text] [Related]
3. Common and rare ABCA1 variants affecting plasma HDL cholesterol.
Wang J; Burnett JR; Near S; Young K; Zinman B; Hanley AJ; Connelly PW; Harris SB; Hegele RA
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1983-9. PubMed ID: 10938021
[TBL] [Abstract][Full Text] [Related]
4. Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population?
Pajukanta P
J Clin Invest; 2004 Nov; 114(9):1244-7. PubMed ID: 15520856
[TBL] [Abstract][Full Text] [Related]
5. Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL.
Soro-Paavonen A; Naukkarinen J; Lee-Rueckert M; Watanabe H; Rantala E; Soderlund S; Hiukka A; Kovanen PT; Jauhiainen M; Peltonen L; Taskinen MR
J Lipid Res; 2007 Jun; 48(6):1409-16. PubMed ID: 17372331
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol.
Candini C; Schimmel AW; Peter J; Bochem AE; Holleboom AG; Vergeer M; Dullaart RP; Dallinga-Thie GM; Hovingh GK; Khoo KL; Fasano T; Bocchi L; Calandra S; Kuivenhoven JA; Motazacker MM
Atherosclerosis; 2010 Dec; 213(2):492-8. PubMed ID: 20880529
[TBL] [Abstract][Full Text] [Related]
7. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux.
Marcil M; Brooks-Wilson A; Clee SM; Roomp K; Zhang LH; Yu L; Collins JA; van Dam M; Molhuizen HO; Loubster O; Ouellette BF; Sensen CW; Fichter K; Mott S; Denis M; Boucher B; Pimstone S; Genest J; Kastelein JJ; Hayden MR
Lancet; 1999 Oct; 354(9187):1341-6. PubMed ID: 10533863
[TBL] [Abstract][Full Text] [Related]
9. Effect of ABCA1 mutations on risk for myocardial infarction.
Iatan I; Alrasadi K; Ruel I; Alwaili K; Genest J
Curr Atheroscler Rep; 2008 Oct; 10(5):413-26. PubMed ID: 18706283
[TBL] [Abstract][Full Text] [Related]
10. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
[TBL] [Abstract][Full Text] [Related]
11. Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype.
Mantaring M; Rhyne J; Ho Hong S; Miller M
Transl Res; 2007 Apr; 149(4):205-10. PubMed ID: 17383594
[TBL] [Abstract][Full Text] [Related]
12. [The role of transmembrane lipidtransporter molecules in the atherosclerotic process].
Harangi M; Köbling T; Paragh G
Orv Hetil; 2006 Feb; 147(6):251-7. PubMed ID: 16610615
[TBL] [Abstract][Full Text] [Related]
13. ATP-binding cassette transporter A1 (ABCA1) in macrophages: a dual function in inflammation and lipid metabolism?
Schmitz G; Kaminski WE; Porsch-Ozcürümez M; Klucken J; Orsó E; Bodzioch M; Büchler C; Drobnik W
Pathobiology; 1999; 67(5-6):236-40. PubMed ID: 10725792
[TBL] [Abstract][Full Text] [Related]
14. HDL, cholesterol efflux, and ABCA1: Free from good and evil dualism.
Ogura M
J Pharmacol Sci; 2022 Oct; 150(2):81-89. PubMed ID: 36055755
[TBL] [Abstract][Full Text] [Related]
15. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter.
Santamarina-Fojo S; Peterson K; Knapper C; Qiu Y; Freeman L; Cheng JF; Osorio J; Remaley A; Yang XP; Haudenschild C; Prades C; Chimini G; Blackmon E; Francois T; Duverger N; Rubin EM; Rosier M; Denèfle P; Fredrickson DS; Brewer HB
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7987-92. PubMed ID: 10884428
[TBL] [Abstract][Full Text] [Related]
16. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
[TBL] [Abstract][Full Text] [Related]
17. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency.
Marcil M; Bissonnette R; Vincent J; Krimbou L; Genest J
Circulation; 2003 Mar; 107(10):1366-71. PubMed ID: 12642355
[TBL] [Abstract][Full Text] [Related]
18. ABCA1 and atherosclerosis.
Soumian S; Albrecht C; Davies AH; Gibbs RG
Vasc Med; 2005 May; 10(2):109-19. PubMed ID: 16013195
[TBL] [Abstract][Full Text] [Related]
19. ABCA1: at the nexus of cholesterol, HDL and atherosclerosis.
Attie AD
Trends Biochem Sci; 2007 Apr; 32(4):172-9. PubMed ID: 17324574
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population.
Frikke-Schmidt R
Atherosclerosis; 2010 Feb; 208(2):305-16. PubMed ID: 19596329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
